Being such a highly heterogeneous disease in terms of clinical course and biological behavior, BC was only successfully classified through molecular and genomic tools, as luminal A, luminal B, human epidermal growth factor receptor 2 (HER2), basal, and normal-like subtypes [2]. The gene discussed is ERBB2; the disease is breast cancer.